Correlation Between Exelixis and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Exelixis and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Akero Therapeutics, you can compare the effects of market volatilities on Exelixis and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Akero Therapeutics.
Diversification Opportunities for Exelixis and Akero Therapeutics
-0.05 | Correlation Coefficient |
Good diversification
The 3 months correlation between Exelixis and Akero is -0.05. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Exelixis i.e., Exelixis and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Exelixis and Akero Therapeutics
Given the investment horizon of 90 days Exelixis is expected to generate 0.54 times more return on investment than Akero Therapeutics. However, Exelixis is 1.87 times less risky than Akero Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Akero Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 3,368 in Exelixis on October 20, 2024 and sell it today you would earn a total of 252.00 from holding Exelixis or generate 7.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Exelixis vs. Akero Therapeutics
Performance |
| Timeline |
| Exelixis |
| Akero Therapeutics |
Exelixis and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exelixis and Akero Therapeutics
The main advantage of trading using opposite Exelixis and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |